Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abstract, accreted, accretion, addressed, aim, aimed, Alfasigma, alliance, arbitration, atrophy, attached, attestation, BCF, BDD, biofilm, blog, Bloomberg, break, cancellation, cancelled, cap, Carlo, Cellular, Certificate, coating, convenience, convenient, departure, disagreement, disclaimer, dispersion, dollar, EHA, element, EMA, erosion, Exit, explanatory, feature, firmly, flexibility, floor, fundraising, gamma, gateway, Heaton, hub, implant, intercompany, intestine, intrinsic, invalidate, Ireland, isotope, issuable, jeopardize, lapse, lattice, layer, leasehold, left, licensee, Monte, movement, mucosal, multidose, MYC, OralogiK, orderly, paragraph, partnership, Penn, pill, Pinnacle, PLLC, premise, principle, proportion, radio, rapidly, redemption, renew, renewed, safer, salivary, satisfactorily, session, simulation, specialty, standing, strong, subtenant, tablet, taxpayer, territorial, thereunder, threatened, tied, topline, trailing, UC, umbrella, underway, upfront, Utah
Removed:
abacavir, abbreviated, accessing, accurately, acquiring, added, allele, analyst, anticipation, apparent, arisen, arm, assessing, Bangladesh, baseline, began, Black, boxed, capable, challenged, combined, commenced, complicating, concentrating, conflicting, consultancy, CTIX, dated, defeated, detection, dual, finance, footnote, Foundation, Hong, hypersensitivity, IGA, improving, integrated, invest, Kong, leaving, lessee, lessor, Malaysia, mark, metabolized, mild, moderate, moiety, occupied, offer, optionee, originally, otic, participating, pertain, play, preclude, provisional, psoriatic, ratio, receivable, rental, renting, resale, reserved, resold, Restoration, restrictive, RNA, role, screening, structured, subscription, suggesting, sulfate, supplement, supported, synthesized, Thailand, transplanted, unchanged, unissued, venture, vivo, xenograft, Ziagen
Filing tables
Filing exhibits
IPIX similar filings
Filing view
External links
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-220419) and Form S-8 (File No. 333-212549, 333-212551) of our report dated September 11, 2018, with respect to the financial statements of Innovation Pharmaceuticals Inc. included in the Annual Report on Form 10-K for the year ended June 30, 2019.
/s/ BAKER TILLY VIRCHOW KRAUSE, LLP
Minneapolis, Minnesota
September 30, 2019